|
Valoración de DCF de Lipocine Inc. (LPCN)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Lipocine Inc. (LPCN) Bundle
Ya sea que sea un inversor o analista, esta calculadora DCF de Lipocine Inc. (LPCN) es su herramienta esencial para una valoración precisa. Equipado con datos reales del lipocino, puede ajustar los pronósticos e inmediatamente observar los efectos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .0 | 16.1 | .5 | -2.9 | -.7 | -.2 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -100 | 0 | -96.9 | -670.16 | -74.23 | -74.23 | -74.23 | -74.23 | -74.23 |
| EBITDA | -12.6 | -18.0 | -.4 | -10.7 | -16.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -7666.19 | 100 | -2.67 | -2144.28 | 572.56 | -0.53346 | -0.53346 | -0.53346 | -0.53346 | -0.53346 |
| Depreciation | .0 | .0 | .0 | .0 | .0 | -.2 | .0 | .0 | .0 | .0 |
| Depreciation, % | 9.36 | 100 | 0.00235428 | 1.89 | -1.01 | 22.05 | 22.05 | 22.05 | 22.05 | 22.05 |
| EBIT | -12.7 | -18.0 | -.4 | -10.7 | -16.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -7675.55 | 100 | -2.67 | -2146.17 | 573.57 | -0.53393 | -0.53393 | -0.53393 | -0.53393 | -0.53393 |
| Total Cash | 14.1 | 19.7 | 44.6 | 32.5 | 22.0 | -.4 | -.1 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .2 | .7 | .1 | -.3 | -.1 | .0 | .0 | .0 |
| Account Receivables, % | 10.01 | 100 | 1.53 | 131.97 | -1.83 | 41.94 | 41.94 | 41.94 | 41.94 | 41.94 |
| Inventories | 5.0 | 5.0 | .0 | .0 | .0 | -.3 | -.1 | .0 | .0 | .0 |
| Inventories, % | 3030.49 | 100 | 0 | 0.0002 | 0 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | 1.2 | 1.6 | 1.3 | .6 | 1.4 | -.4 | -.1 | .0 | .0 | .0 |
| Accounts Payable, % | 716.55 | 100 | 7.99 | 120.08 | -48.97 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| Capital Expenditure | .0 | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | 100 | -0.04702978 | -26.77 | 0.46187 | -5.36 | -5.36 | -5.36 | -5.36 | -5.36 |
| Tax Rate, % | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 |
| EBITAT | -12.7 | -18.0 | -.4 | -10.7 | -16.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.5 | -17.6 | 4.0 | -12.0 | -14.9 | -1.2 | -.2 | -.1 | .0 | .0 |
| WACC, % | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 | 10.05 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | 0.64 |
What You Will Get
- Real LPCN Financial Data: Pre-filled with Lipocine Inc.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Lipocine Inc.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue projections, operating margins, and research & development expenses.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Results: Leverages Lipocine Inc.'s (LPCN) actual financial data for accurate valuation outputs.
- Effortless Scenario Testing: Easily explore various assumptions and analyze their impact on outcomes.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- 1. Access the Template: Download and open the Excel file containing Lipocine Inc.'s (LPCN) preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Lipocine Inc. (LPCN)?
- Designed for Experts: A specialized tool utilized by analysts, CFOs, and investment consultants.
- Accurate Financial Data: Lipocine Inc.'s historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance makes the process straightforward.
Who Should Use Lipocine Inc. (LPCN)?
- Healthcare Investors: Make informed investment choices with comprehensive analysis of Lipocine's pipeline and market potential.
- Pharmaceutical Analysts: Streamline your research with detailed reports on Lipocine's drug development progress and financial performance.
- Consultants: Easily modify presentations or reports to highlight Lipocine's strategic initiatives and market positioning.
- Biotech Enthusiasts: Enhance your knowledge of biopharmaceutical innovations and their impact on health outcomes through Lipocine's case studies.
- Educators and Students: Utilize Lipocine as a real-world example in pharmacology and business courses to illustrate industry concepts.
What the Template Contains
- Pre-Filled DCF Model: Lipocine Inc.'s (LPCN) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Lipocine Inc.'s (LPCN) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.